FRACTYL HEALTH, INC.

Highlights Fractyl Health, Inc.

Equities

GUTS

US35168W1036

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
6.1 ^USD	-1.45%		-3.79%	0.00%

May. 13	Earnings Flash (GUTS) FRACTYL HEALTH Reports Q1 Revenue $33,000	MT
May. 13	Fractyl Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (GUTS) FRACTYL HEALTH Reports Q1 Revenue $33,000	May. 13	MT
Fractyl Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Fractyl Health Says New Revita Data Show Sustained Weight Loss, Glucose Control in Type 2 Diabetes	May. 13	MT
Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures	Apr. 01	MT
Rising Rate Cut Hopes Buoy Exchange-Traded Funds, Equity Futures Pre-Bell Monday	Apr. 01	MT
Top Premarket Decliners	Apr. 01	MT
Fractyl Health Shares Drop After Wider 4Q Loss	Apr. 01	DJ
Earnings Flash (GUTS) FRACTYL HEALTH Posts Q4 Revenue $7,000	Apr. 01	MT
Fractyl Health, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Apr. 01	CI
Fractyl Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Fractyl Health Shares Rise 40% After FDA Approval of IDE for Revita	Apr. 01	DJ
Fractyl Health, Inc. Receives FDA IDE Approval for the Revita®? Remain-1 Pivotal Study of Weight Maintenance in Obesity After Discontinuation of GLP-1 Based Drugs	Apr. 01	CI
Fractyl Health Reports 'Promising' Preclinical Findings From Rejuva Platform; Shares Fall	Mar. 12	MT
Fractyl Health Announces New Results from Its Rejuva® Platform Demonstrating Potent and Durable Effects of A Single Dose of A Human Glp-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the Db/Db Mouse Model of Diabetes and Obesity	Mar. 12	CI
Fractyl Health, Inc. has completed an IPO in the amount of $109.999995 million.	Feb. 01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW